Royalty Pharma plcRPRXNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank40
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P40
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-10.25%
2024-24.31%
20232549.50%
2022-93.09%
2021-36.44%
2020-58.48%
201970.46%
201813.86%
2017113.82%
2016-2.67%